Posted by Michael Wonder on 24 Mar 2020
COVID-19: hydroxychloroquine
24 March 2020 - There has been a lot of interest around the use of hydroxychloroquine for treatment of COVID-19 cases.
There has not been any specific evidence to confirm its efficacy for this indication.
Effective from Tuesday, 24 March 2020, PHARMAC has restricted funded access to this medicine to make sure it is available for patients who need it for its registered indications.
